Renaissance Technologies’s Acrivon Therapeutics ACRV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $606K | Buy |
509,295
+457,195
| +878% | +$544K | ﹤0.01% | 2743 |
|
|
2025
Q1 | $106K | Buy |
52,100
+2,700
| +5% | +$5.48K | ﹤0.01% | 3189 |
|
|
2024
Q4 | $297K | Buy |
49,400
+3,500
| +8% | +$21.1K | ﹤0.01% | 3045 |
|
|
2024
Q3 | $321K | Sell |
45,900
-8,600
| -16% | -$60.2K | ﹤0.01% | 2959 |
|
|
2024
Q2 | $316K | Sell |
54,500
-48,100
| -47% | -$279K | ﹤0.01% | 2889 |
|
|
2024
Q1 | $734K | Buy |
+102,600
| New | +$734K | ﹤0.01% | 2675 |
|